The decision to microdose usually stems from a few practical, real-world challenges that people face when starting GLP-1 treatment
Did a wonderful job
Whether youre defining your pipeline strategy, evaluating launch scenarios, designing access models, or building long-term value across the obesity ecosystem, we bring the insights and rigor needed to lead
Eli Lilly, Novo Nordisk expand operations amid GLP-1 drug boom Biopharma bigwigs Eli Lilly and Novo Nordisk are upping capacity to meet the rising demands of GLP-1 drugs
Emotional and Behavioral Symptoms: People with trichotillomania experience different emotional symptoms, like feelings of guilt, shame, and anxiety
however, the specific mechanism remains unclear